glp-1 news september 2025 The New Health Consumer Mindset and Wallet: From GLP-1s to Trading Up for Health & Longevity glp-1 news september 30 2025

Its the reason the FDA has been hesitant to approve GLP-1 use for people with type 1 diabetes, says Dace Trence, MD, the president of American Association of Clinical Endocrinology and a professor emeritus at the University of Washington in Seattle

Meanwhile, Novo Nordisk and Eli Lilly surged into the ranks of the worlds most valuable companies, pipelines swelling with oral formulations, dual and triple agonists, and weight-loss hybrids that fold in amylin and other pathways

August 9th, 2025: Lawsuits Mount Over Vision Loss Risks Linked to Ozempic, Wegovy, and Mounjaro New research has suggested a possible connection between GLP-1 receptor agonist drugsincluding Ozempic, Wegovy, and Mounjaroand heightened risks of severe eye conditions such as neovascular age-related macular degeneration (nAMD) and nonarteritic anterior ischemic optic neuropathy (NAION)

What This Means for You If youre considering GLP-1 medications, talk with your healthcare provider about the potential benefits and risks

As a 29-amino-acid peptide that corresponds to the first 29 amino acids of natural GHRH, sermorelin stimulates natural growth hormone production without the supraphysiological peaks associated with exogenous GH administration

[DOI] [PubMed] [Google Scholar] 61.Vilarrasa E., Nicolau J., de la Cueva P., Goday A., Gallardo F., Martorell-Calatayud A., Carrascosa J.M